News

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

4 June 2024

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.

  • Reset
Avance Clinical Leads DCT Technology Adoption Globally

10 April 2023

Avance Clinical Leads DCT Technology Adoption Globally

GlobalData and Clinical Trial Arena have identified Avance Clinical as the global leader in Decentralized Clinical Trial (DCT) technology adoption with 46% of their trials incorporating some elements of DCT technologies in 2022 including telemedicine, remote monitoring, and digital data collection.

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

27 March 2023

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in the fourth quarter of 2023

Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise

1 March 2023

Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise

Avance Clinical today announced the appointment of John Mann as Senior Vice President, North America Operations.

Avance Clinical Expands Biometrics Team into India to Support Biotech Trials Demand in US and Australia

13 February 2023

Avance Clinical Expands Biometrics Team into India to Support Biotech Trials Demand in US and Australia

Award-winning CRO Avance Clinical, which currently has the largest Biometrics team in Australia, is expanding further with global hires and a specialist hub in Bangalore, India to support growing demand.

Avance Clinical Celebrates GlobalReady Success as More Than 40 Biotechs Enter Program

11 January 2023

Avance Clinical Celebrates GlobalReady Success as More Than 40 Biotechs Enter Program

More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady program which delivers streamlined clinical development from early phase in Australia expanding to sites in North America for later phases.

New Analyst Report – Avance Clinical GlobalReady for Biotechs

12 December 2022

New Analyst Report – Avance Clinical GlobalReady for Biotechs

Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient.

Avance Clinical Wins Frost & Sullivan Customer Value Leadership Award 2022

7 December 2022

Avance Clinical Wins Frost & Sullivan Customer Value Leadership Award 2022

After an extensive review by CRO industry analysts comprising executive interviews and background sector research, Frost & Sullivan has recognized Avance Clinical, the leading Australian-based biotech CRO with US operations, with the Frost & Sullivan’s 2022 Asia-Pacific Customer Value Leadership Award.

Avance Clinical Sponsors China BioPharma Award at the Global Scrip Awards, London

27 October 2022

Avance Clinical Sponsors China BioPharma Award at the Global Scrip Awards, London

Avance Clinical, the leading Australian-based biotech CRO with US operations will sponsor and present the China BioPharma Award at the global biotech Scrip Awards in London next month.

Avance Clinical Wins International Health Award for Biotech CRO Services

28 September 2022

Avance Clinical Wins International Health Award for Biotech CRO Services

Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier’s Export Awards – International Health category. The award recognizes excellence in clinical services exports.

Avance Clinical announces North American CRO acquisition to expand later phase services for Biotechs

6 September 2022

Avance Clinical announces North American CRO acquisition to expand later phase services for Biotechs

Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside Company for their global expansion program.

Avance Clinical Featured in Oracle Argus Capabilities Spotlight

24 August 2022

Avance Clinical Featured in Oracle Argus Capabilities Spotlight

Avance Clinical presented real world experience supporting biotech clinical trials using Oracle Argus. Hear from Avance Clinical’s Chief Scientific Officer Gabriel Kremmidiotis, and Drug Safety Manager Pilar Garzon.

Avance Clinical MedTech Featured in Endpoints News – Most read article for the month

24 August 2022

Avance Clinical MedTech Featured in Endpoints News – Most read article for the month

Innovative MedTech covers everything from physical devices, artificial intelligence (AI) and machine learning and digital healthcare, including biosensors in wearables like a watch, to a skin patch, or ingested or implanted devices.

Proven industry
experience & expertise

500+

Studies in the past 5 years

330+

Experienced team members

18k+

Participants past 5 years

30

Years of CRO experience